Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-31,144
Closed -$5.05M 59
2022
Q1
$5.05M Sell
31,144
-2,617
-8% -$380K 1.51% 30
2021
Q4
$4.57M Buy
33,761
+245
+0.7% +$28.9K 1.35% 30
2021
Q3
$3.62M Buy
33,516
+394
+1% +$45K 1.08% 41
2021
Q2
$3.73M Buy
33,122
+2,747
+9% +$309K 1.1% 40
2021
Q1
$3.29M Sell
30,375
-2,872
-9% -$307K 0.97% 45
2020
Q4
$3.56M Buy
33,247
+1,064
+3% +$102K 1.06% 36
2020
Q3
$2.82M Buy
32,183
+399
+1% +$37.6K 0.96% 43
2020
Q2
$3.12M Sell
31,784
-4,323
-12% -$381K 1.12% 35
2020
Q1
$2.75M Sell
36,107
-455
-1% -$38.8K 1.15% 41
2019
Q4
$3.24M Buy
36,562
+434
+1% +$36K 1.16% 41
2019
Q3
$2.74M Buy
36,128
+384
+1% +$26.3K 1.11% 42
2019
Q2
$2.6M Buy
35,744
+6,337
+22% +$498K 1.04% 52
2019
Q1
$2.37M Buy
29,407
+765
+3% +$62.6K 1.06% 49
2018
Q4
$26.4M Buy
28,642
+4,417
+18% +$388K 1.26% 40
2018
Q3
$2.26M Buy
24,225
+309
+1% +$29.3K 0.94% 50
2018
Q2
$2.22M Buy
+23,916
New +$2.34M 0.97% 52

Other funds holding ABBV

BCWM LLC's ABBV Position: Q2 2022 in Review

BCWM LLC sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 31,144 shares — an estimated $5.05M sold.

BCWM LLC first reported a position in ABBV in Q2 2018 and held it in 16 quarters. The position peaked at $26.4M in Q4 2018. 3,004 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • BCWM LLC reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
  • BCWM LLC sold 31,144 AbbVie shares in Q2 2022, an estimated $5.05M.
  • BCWM LLC first reported a position in AbbVie in Q2 2018 and held it in 16 quarters.
  • BCWM LLC's AbbVie position peaked at $26.4M in Q4 2018.
  • 3,004 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on BCWM LLC's 13F filing for Q2 2022, filed 11 Aug 2022.